Anbio Biotechnology (NNNN) vs Utah Medical Products, Inc. (UTMD)

Anbio Biotechnology and Utah Medical Products, Inc. are both Medical Instruments & Supplies companies. Anbio Biotechnology is the larger, with a market value of $474.8M against $237.8M — 2.0× the size. Across the 8 metrics below, Utah Medical Products, Inc. leads on 6 and Anbio Biotechnology on 2.

Valuation

Metric NNNN UTMD Medical Instruments & Supplies median
P/E — 22.72 33.75
P/S — 6.57 2.52
P/B n/m 1.94 2.48
Price to free cash flow n/m 20.73 25.19
EV/EBITDA n/m 11.84 14.62
EV/Sales n/m 4.17 2.88
Earnings yield — 4.40% (2.67%)
Free cash flow yield 0.00% 4.83% 0.09%

Profitability

Metric NNNN UTMD Medical Instruments & Supplies median
Gross margin — 57.90% 54.29%
Operating margin — 28.43% 1.07%
Net margin — 29.04% (1.61%)
Free cash flow margin 0.00% 31.70% 1.08%
Return on equity 0.00% 8.75% (1.32%)
Return on assets 0.00% 8.55% 0.00%
Return on invested capital 0.00% 18.60% 0.00%

Growth

Metric NNNN UTMD Medical Instruments & Supplies median
Revenue growth (TTM) — (7.00%) 8.85%
EPS growth (last fiscal year) 150.00% (12.12%) 8.65%
Revenue growth, 5-year CAGR — (1.80%) 9.17%
Net income growth, 5-year CAGR — 0.89% 0.00%

Health

Metric NNNN UTMD Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.10
Current ratio 344.45 48.62 2.48
Net debt to EBITDA (2.06) (5.95) 0.89

Dividend

Metric NNNN UTMD Medical Instruments & Supplies median
Dividend yield — 1.66% 1.11%
Payout ratio — 0.38 0.27

Size

Metric NNNN UTMD Medical Instruments & Supplies median
Market cap 474.84m 237.78m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack